A new study concludes that molecular breast imaging (MBI), a newer form of breast cancer screening also called Breast-Specific Gamma Imaging (BSGI), is superior to the more traditional ultrasound and mammography methods of screening. It's sensitivity to finding breast cancer detection was 91% compared to 74% and 84% for the other two methods (respectively).
The study, published in the January 2012 issue of the American Journal of Roentgenology, compared 1,042 patients from four institutions to find the results. The study used a high resolution BSGI camera against two standard mammography and ultrasound machines and methods.
In many cases, the BSGI was used as a follow up second opinion to an original diagnosis of breast cancer from one of the other two methods. The researchers found that in this case, the BSGI was more reliable in changing false diagnosis for better patient management.
The information provided on Breastcancer.co is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of Breastcancer.co nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
SupportGroups.com provides a support network for those dealing with breast cancer and other types of cancer as well as many other life challenges. Click on the following links to get the support in a confidential, caring environment.
